RATIONALE: Biological therapies such as KRN7000 use different ways to stimulate the immune
system and stop cancer cells from growing.
PURPOSE: Phase I trial to study the effectiveness of KRN7000 in treating patients who have
solid tumors that have not responded to previous treatment.
Phase:
Phase 1
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC